Osaka, Japan

Hidenori Abe

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidenori Abe. Retrieved from https://idiyas.com/inventor/hidenori-abe-vs9672h8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hidenori Abe: Innovator in Imidazopyridine Compounds

Introduction

Hidenori Abe is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of imidazopyridine and imidazopyrimidine compounds. His work has implications for various applications in pharmaceuticals and beyond.

Latest Patents

Hidenori Abe holds a patent for "Imidazopyridine or imidazopyrimidine compounds, their production and use." This patent highlights his innovative approach to creating compounds that can be utilized in various chemical processes.

Career Highlights

Abe is currently employed at Takeda Chemical Industries, Inc., a leading global pharmaceutical company. His role at Takeda allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Kyoko Iida and Muneo Takatani. Their collaboration fosters a dynamic environment for innovation and enhances the potential for new discoveries in their field.

Conclusion

Hidenori Abe's contributions to the field of chemistry, particularly through his patent on imidazopyridine compounds, showcase his innovative spirit and dedication to advancing scientific knowledge. His work at Takeda Chemical Industries, Inc. continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…